Healthium Medtech IPO GMP Price, Date, Review Details - IPO Upcoming

Last Updated on

Sep 8, 2023 1:18 PM

in

Written By

Healthium Medtech is a multinational medical technology firm that specializes in chronic, post-surgery, and surgical care. The company’s vision is to provide every patient in the world with access to precision medical technology products.

In this Article

With more than 52,000 SKUs, Healthium Medtech has a substantial product base relevant to its key areas. In India and the UK, the brand has a fantastic commercial presence and market access. They export goods to more than 80 nations, including South America, Asia, and America, as well as the US, UK, Germany, and France (established markets). The brand stands out from its competitors because of its extensive selection of high-quality products at enticing prices.

Healthium Medtech IPO Objectives

Here are a few quick reasons why Healthium Medtech is going public:

The fund will be used to create awareness and visibility of the company among existing and potential customers.
investment of the fund into the brand’s subsidiaries, Sironix, Clinisupplies and Quality Needles.

Healthium Medtech IPO Financials

Particulars	2021	2020	2019
Revenue from operations (₹ million)	7,133.57	6,391.79	5,840.20
Restated profit before tax (₹ million)	1,130.33	578.81	243.04
Restated profit for the year (₹ million)	854.28	367.60	137.31
Gross margin (%)	62.33%	65.89%	65.26%
EBITDA (₹)	1,539.27	955.74	544.27
EBITDA margin (%)	21.58%	14.95%	9.32%
ROE (%)	21.57%	10.98%	3.57%
ROCE (%)	22.98%	16.08%	6.45%
Cash conversion cycle (in days)	139	171	219
Net cash flow from operating activities (₹ million)	1,221.29	589.24	514.38
Net cash flows from/ (used in) operating activities / EBITDA (%)	79.34%	61.65%	94.51%

Why should you invest in the Healthium Medtech IPO?

In India, Healthcare is among the fastest-growing markets in terms of revenue.
As per Frost & Sullivan analysis, during the years 2021–2025, the Indian healthcare market is expected to grow at a steady rate of 13.9%.

Healthium Medtech Limited IPO consists of a fresh issue of equity shares of Rs 390 crore plus an offer of sale of up to 39.10 million shares by current shareholders and promoters. Healthium Medtech has established itself as the largest medical device company and the second-largest one in the surgical consumables market in India.

Know before investing

Strengths

Due to the brand’s strong global reach, it is subject to favorable industry dynamics in high-growth markets.
The company’s R&D department has a proven track record of successfully commercializing its products.
The brand’s strong presence in India and several other countries (UK, US, Europe, etc.) has created a strong market reach for them.

Risks

Any health pandemic, social unrest, or natural disaster can affect the business adversely.
Any delay from the vendors can adversely affect the business.
Inflation in India can adversely affect business.

Healthium Medtech IPO FAQs:

Q1. What is Healthium Medtech IPO?

Ans. Healthium Medtech Limited IPO consists of fresh issue of equity shares of Rs 390 Cr. Plus, with an offer of sale of up to 39.10 million shares by current shareholders and promoters.